Seattle Genetics
| Use attributes for filter ! | |
| Stock price | SGEN |
|---|---|
| Disclaimer | |
| Number of employees | > 900 |
| Ceo | Clay B Siegall |
| Headquarters | Bothell |
| Washington | |
| United States | |
| Subsidiary | Oncothyreon, Inc. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046072 |
About Seattle Genetics
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.
